Medtronic plc (NYSE:MDT) 2024 Barclays 26th Annual Healthcare Conference Call March 12, 2024 8:00 AM ET Company Participants Karen Parkhill - CFO Conference Call Participants Matt Miksic - Barclays Matt Miksic Good morning. Thanks so much for joining us. My name is Matt Miksic, I’m US Medical Device Analyst here at Barclays, and we are very pleased to have with us today Medtronic, specifically, CFO, Karen Parkhill, so thanks again so much for joining us. Karen Parkhill Thank you, Matt. Great to be here. Mat ...

Merck & Co., Inc. (NYSE:MRK) Barclays 26th Annual Global Healthcare Conference March 12, 2024 3:05 PM ET Company Participants Jannie Oosthuizen - President, Human Health U.S. Peter Dannenbaum - Vice President, Investor Relations Conference Call Participants Carter Gould - Barclays Carter Gould Good afternoon and welcome to Day One of the Barclays Global Healthcare Conference. My name is Carter Gould, covering U.S. Biopharma. I'm pleased to welcome Merck to the stage. Merck is one of our top picks to start t ...

Editas Medicine, Inc. (NASDAQ:EDIT) Leerink Partners Global Biopharma Conference March 12, 2024 10:40 AM ET Company Participants Gilmore O'Neill - CEO Erick Lucera - Conference Call Participants Mani Foroohar - Leerink Mani Foroohar Good morning, everyone. Welcome back to the 2024 Global Biopharma Conference, Inaugural Miami Conference. So welcome everybody down. I am Mani Foroohar, Senior Analyst Genetic Medicines. And I'm very fortunate to be hosting the team from Editas Medicine. How are you doing? Gilm ...

AT&T Inc. (NYSE:T) Deutsche Bank's 32 Annual Media, Internet & Telecom Conference March 12, 2024 1:00 PM ET Company Participants Pascal Desroches - Chief Financial Officer Conference Call Participants Bryan Kraft - Deutsche Bank Bryan Kraft Okay. Welcome, everyone. Welcome back again. I'm excited to introduce our next guest on the stage here. Pascal Desroches, the Chief Financial Officer of AT&T. Pascal, welcome. Pascal Desroches Hey, it's a pleasure to be here. Hello, everybody. Maybe before I forget, I'm ...

Summary of Southwest Airlines Conference Call Company Overview - **Company**: Southwest Airlines Co. (NYSE:LUV) - **Event**: J.P. Morgan 2024 Industrials Conference - **Date**: March 12, 2024 Key Points Operational Improvements - Southwest Airlines has implemented a comprehensive winter weather action plan, successfully tested during various winter weather events, leading to stable crew and aircraft networks [3] - The company achieved a 99.3% completion factor since February 1, marking February as the highest completion factor on record since 1997 [7][8] - First quarter capacity is expected to increase approximately 11% year-over-year, up from a previous estimate of 10% [8] Financial Performance - Revenue per available seat mile (RASM) guidance for the first quarter has been updated to a range of flat to 2% year-over-year, reflecting a 2.5-point decrease from prior expectations [8][9] - Despite challenges, the company anticipates another quarter of record revenue, with strong demand and improved operational performance [9][10] Labor Agreements - Southwest has ratified agreements with six out of eight labor groups, including pilots, and is optimistic about finalizing the remaining contracts [4] Cost Management - Non-fuel costs are projected to rise approximately 6% year-over-year for the first quarter, primarily due to salary and maintenance expenses [11] - The company has halted hiring for customer support and flight attendant positions, reducing pilot hiring by over 50% and flight attendant hiring by over 60% for 2024 [12][13] Boeing Delivery Delays - Boeing has revised its delivery schedule, now expecting to deliver 46 MAX 8 aircraft in 2024, down from 58 [15] - The company is adjusting its fleet plan to mitigate risks associated with these delays, focusing on maintaining operational efficiency and cost management [16][17] Future Outlook - The company is not providing a full-year 2024 outlook due to the recent changes in aircraft delivery schedules [15] - Southwest aims to achieve a full-year capacity growth of 4.5% to 5% year-over-year, with adjustments being made to optimize schedules [17] Sustainability Initiatives - Southwest aims for 10% of its fuel usage to be sustainable aviation fuel (SAF) by 2030, with a long-term goal of net zero emissions by 2050 [51][52] - The company has formed a subsidiary, Southwest Airlines Renewable Ventures, to invest in sustainable fuel projects [54] Customer Loyalty and Revenue Initiatives - The Rapid Rewards loyalty program is performing well, with record memberships and revenues [36] - The company is exploring new revenue initiatives and enhancements to the loyalty program, including potential partnerships and new features [38][39] Competitive Landscape - The company acknowledges competitive pressures from other airlines, particularly regarding change fee policies and customer service initiatives [24][25] - Southwest remains committed to its core values of customer service and operational efficiency, which it believes will sustain its competitive advantages [20] Conclusion - Southwest Airlines expresses optimism about its future, emphasizing its strong operational performance, commitment to cost management, and focus on sustainable growth [19][21]

Johnson & Johnson (NYSE:JNJ) Leerink Partners Global Biopharma Conference March 12, 2024 1:00 PM ET Company Participants Joe Wolk - Chief Financial Officer Raychel Kruper - Senior Director of Investor Relations Conference Call Participants David Risinger - Leerink Partners David Risinger Okay. So, we're going to get started here. Sorry, we're starting two minutes late. My apologies. So, my name is Dave Risinger. If you don't know me, I cover diversified biopharmaceuticals for Leerink Partners. And it's very ...

Sanofi (NASDAQ:SNY) Leerink Partners Global Biopharma Conference March 12, 2024 10:40 AM ET Company Participants Naimish Patel - Global Head of Development for Immunology and Inflammation Shaju Backer - Global Head of Immunology Franchise Conference Call Participants Dave Risinger - Leerink Partners Dave Risinger All right. Good morning, everyone. So my name is Dave Risinger, I cover Diversified Biopharmaceuticals for Leerink Partners, and it’s very much my pleasure to welcome you to the session with Sanofi ...

Pfizer Inc. (NYSE:PFE) Leerink Partners Global Biopharma Conference 2024 Call March 12, 2024 8:00 AM ET Company Participants Ronen Tamir - Vice President, Investor Relations Mikael Dolsten - Chief Scientific Officer & President, Pfizer Research and Development Conference Call Participants David Risinger - Leerink Partners David Risinger Good morning, everybody. So it's very much my pleasure to start off the day today with Pfizer's Head of R&D, Mikael Dolsten. It's very much my pleasure to welcome him. And R ...

American Airlines Group Inc. (NASDAQ:AAL) J.P. Morgan 2024 Industrials Conference Call March 12, 2024 9:15 AM ET Company Participants Robert Isom - Chief Executive Officer Devon May - Chief Financial Officer Conference Call Participants Jamie Baker - JPMorgan Mark Streeter - JPMorgan Jamie Baker All right, folks, moving right along. For any of you that were in the room for the United presentation, I was right, Mike Leskinen is the most recently seated CFO in the U.S. So, I stand by what I thought for a mome ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Barclays 26th Annual Global Healthcare Conference Transcript March 12, 2024 11:15 AM ET Executives Chris Fenimore - Chief Financial Officer Ryan Crowe - Vice President, Investor Relations Analysts Carter Gould - Barclays Carter Gould Great. All right. Good morning. And welcome to the Barclays Global Healthcare Conference. My name is Carter Gould covering large-cap biopharma here at Barclays. Welcome, everyone. I’m pleased to welcome Regeneron Pharmaceuticals to ...